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1. Introduction
  Statins are HMG coenzyme A reductase inhibitors[1],this 
kind of drug can competitively inhibit endogenous 
cholesterol synthesis rate-limiting enzyme reductase, block 
the intracellular mevalonate pathway, reduce intracellular 
cholesterol synthesis, then stimulate LDL more on cell 
surface[2],increase the activity and the number of receptors 
and serum cholesterol removal, which is widely used 
in clinical to regulate blood lipids. Recent studies have 
found that statins can not only regulate blood lipids, but 
also protect cardiovascular, such as delay atherosclerosis, 
inhibit endothelial inflammation, anti-inflammatory and 
anti-thrombosis[3]. This study established myocardial 
ischemia-reperfusion model to explore the impact of 
atorvastatin on serum oxidative stress and N-terminal brain 
natriuretic peptide expression.
2. Materials and methods
2.1. Animals, reagents and instruments
  40 male SD (Spragu-Dawley) rats weighing 250-300 g 
Objective: To investigate the effect of atorvastatin on serum oxidative stress and N-terminal 
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total superoxide dismutase (TSOD), and n-terminal pro-brain natriuretic peptide (NT-proBNP) 
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were provided by Beijing Vital River Laboratory Animal 
Technology Co., Ltd. License No.: SCXK (Beijing) 2002-0003.
Atorvastatin (Lipitor; specifications 20 mg; Zhunzi J20120049) 
was purchased from Pfizer. N-amino-arginine (L-NNA) 
was purchased from Shanghai XinRan research reagents 
and detection assays center. Hoechst was purchased 
from Shenyang Biyuntian Institute of Biotechnology. 
Malondialdehyde (MDA) test kit (HY-60003 KIT) was from 
Beijing Huaying Biotechnology Institute. Nitric oxides (NO), 
total superoxide dismutase (TSOD), lactate dehydrogenase 
(LDH), stimulated kinase (CK) kit were from Nanjing 
Jiancheng Bioengineering Institute. High-speed refrigerated 
centrifuge was from Beckman Allerga 25R. High-speed 
desktop centrifuge was from Sigma company. Fluorescent 
spectrophotometer (RF-5301PC) was from Shimadzu 
Corporation. NT-proBNP ELISA kit was from U.S. Rapidbio 
Biosource company. Ultra-low temperature freezer (-86 ℃) 
was from SSNYO Japan.
2.2. Grouping and modeling
  (Group A, n=10, saline 5 mL/d), ischemia-reperfusion 
group (Group B, n=10, saline 5 mL/d), atorvastatin group 
(Group C, n=10, atorvastatin 20 mg/kg•d), atorvastatin + 
N-amino-arginine group (Group D, n=10, atorvastatin 20 mg/
kg•d + N-amino arginine 15 mg/kg). Myocardial ischemia-
reperfusion rat model was established after 3 days of gavage. 
N-amino arginine 15 mg/kg was given by tail vein injection 
15 min before ischemia. 
  The rats were anesthetized with ether at supine position, 
fixed on the operating table. After endotracheal intubation, 
they were connected with ventilator (tidal volume 30 mL, 
frequency of 55 times/min), then connected with II-lead 
ECG for ECG recording[4],meanwhile connected with ECG 
Monitor to observe ECG changes. Chest was opened from 
the 3rd or 4th left intercostal to expose the heart. It was 
threaded at  2-3 mm of left anterior descending branch of 
coronary artery[5] between the left atrium and pulmonary 
artery cone. In sham group only threading was performed 
without ligation, while in the rest groups the coronary 
artery was immediately ligated with No. 0 thread after 15 
min. After 30 min of ischemia, thread was cut to regain 
blood stream. Reperfusion was carried out for 120 min. Rats 
were sacrificed and the hearts were obtained. Successful 
criteria of ligation were as follows: ECG showed ST segment 
elevation or R wave rose; ligature distal myocardial was in 
cyanosis color. Successful criteria of reperfusion were as 
follows: the ligature was loosened to restore coronary blood, 
the color of myocardial ischemic area recover , ST segment 
elevation was reduced by more than 50%[6].
2.3. Index measurement
  After reperfusion, serum enzyme indicators of rats such 
as serum LDH and CK, oxidative stress indicators such as 
NO, MDA and TSOD was measured, and N-terminal brain 
natriuretic peptide precursor expression was detected by 
immunohistochemical assay. After reperfusion for 120 min, 
1 mL carotid artery blood was obtained from each group. 
After centrifugation, the supernatant was collected. CK and 
LDH level was measured according to kit instructions. After 
the hearts removing, the left ventricular anterior wall was 
obtained, the trace of blood was dried by filter paper. It was 
stored in a refrigerator (-70 ℃). After the experiment, the 
MDA was detected by thiobarbituric acid[7], xanthine oxidase 
method was used to detect TSOD, and Griess reagent was 
used to detect serum NO.
  Blood samples were collected on the last day of the 
experiment, serum NT-proBNP levels were quantitatively 
determinated by chemiluminescence method. 
2.4. Statistical analysis
  Data were analyzed by SPSS 16.0 statistics software, t-test 
and 氈
2 testwas adopted and the data were expressed as 
mean依SD values. Repeated measurement data was analyzed 
by variance F test, multiple comparison by LSD-t test.
P<0.05 was regarded as statistical significant difference.
3. Results
3.1. Serum enzymes
  LDH and CK levels of group A were significantly lower 
than the other three groups, and the level in group B was the 
highest. There was significant difference between group B 
and group C (P<0.05), and no significant difference between 
group B and group D (P>0.05) (Table 1).
Table 1
Serum enzymes indicators of rats in each group (mean依SD).
Groups  Number of cases LDH (U/L) CK (毺mol/L)
Group A 10   932.58依15.55 55.89依2.18
Group B 10 1 488.17依71.46*  95.57依1.82*
Group C 10  1 113.34依42.77*#   63.54依3.55*#
Group D 10    1 453.44依37.11*△     93.18依2.17*△
Note: Compared with group A, * P<0.05; compared with group B, # 
P<0.05; compared with group C, △ P<0.05.
3.2. Oxidative stress
  MDA levels in group B were significantly higher than the 
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other three groups, the lowest was group A, followed by 
group C, the difference among groups was significantly 
(P<0.05). TSOD and NO levels in group B was the lowest, the 
levels in group A was the highest, followed by group C, the 
difference among groups was significant (P<0.05) (Table 2).
Table 2
Oxidative stress indicators of rats in each group (mean依SD).
Groups Number
of cases
MDA
(nmol/mgprot)
TSOD
(U/mgprot)
NO
(毺mol/L)
Group A 10 2.35依0.13 135.4依4.2 55.3依3.9
Group B 10  5.00依0.17*   88.9依2.6*  17.5依3.0*
Group C 10  3.54依0.09*#  118.7依3.9*#   40.6依3.1*#
Group D 10   4.93依0.15*△     101.6依4.0*#△    19.2依2.1*△
Note: Compared with group A, * P<0.05; compared with group B, # 
P<0.05; compared with group C, △ P<0.05.
3.3. NT-proBNP determination
  NT-proBNP level in group B was significantly higher than 
the other three groups, the lowest was group A, followed 
by group C, the difference among groups was significantly 
(P<0.05)(Table 3).
Table 3
NT-proBNP determination of rats in each group (mean依SD).
Groups  Number of cases NT-proBNP (pg/mL)
Group A 10 117.61依13.29
Group B 10  293.46依43.31*
Group C 10   184.74依26.89*#
Group D 10      242.25依27.44*#△
Note: Compared with group A, * P<0.05; compared with group B, # 
P<0.05; compared with group C, △ P<0.05.
4. Discussion
  Oxidative stress refers to the imbalance of anti-oxidation 
and oxidation in vivo, which tends to oxidation. It can lead to 
the inflammatory infiltration of neutrophil, protease secretion 
increase, also produce a large number of intermediate 
products, such as free radicals, causing human diseases or 
aging[8]. SD rat occurs reperfusion injury(I/R) after myocardial 
ischemia-reperfusion. The pathological mechanism of I/
R is still not clear in clinical. However, most scholars 
believe that it is closely related to the excessive production 
of oxygen free radicals after minutes of reperfusion and 
intracellular calcium overload or redistribution[9].During 
the first few minutes of reperfusion, the rich blood supply 
caused the outbreak of hydroxyl, superoxide anion, 
peroxynitrite and other oxygen free radical, which can occur 
reaction with various cellular components such as proteins, 
phospholipids, nucleic acids, and lead to cell structure 
damage and functional metabolism disorders[10].Once the 
free radicals are generated, intermediate metabolite can 
extend continuously and generate new free radicals and form 
a chain reaction. During early I/R, the release of free radicals 
and reperfusion-induced anti-oxidants decrease, leading 
to easily damaged myocardial cells. The protective effect of 
endogenous antioxidant system is difficult to remove a large 
number of OFR,meanwhile OFR can stimulate endothelial 
cells to release platelet-activating factor[11,12], and then 
attract the neutrophils, resulting in an increase of oxygen 
free radicals, aggravate the degree of reperfusion injury.
  LDH and CK as serum enzyme indicators for reminder 
myocardial ischemia - reperfusion injury, its levels rise 
showed successful model[13]. In this study, the highest level 
of it is group B, group A has the lowest level, group C is 
closer to group A, which indicated the ischemia-reperfusion 
group have the most serious damage. Atorvastatin may 
inhibit ischemia-reperfusion injury, but after adding NO 
synthase inhibitor L-NNA, the level of group D is closer to 
group B, which showed atorvastatin can reduce I/R injury 
and that is related with increased NO.
  Serum NO reduce is the sign of I/R injury[14,15]. NO is a very 
unstable biological radicals, the generation of which relies 
on the nitric oxide synthase.After NO synthesized into the 
blood, it can promote the body’s blood circulation to protect 
vascular tissue. Meanwhile NO can effectively remove excess 
free radicals and inhibit oxidative stress[16] to maintain 
cardiovascular health. In this study, the lowest level of NO 
is group B, followed by group D, the highest level is in group 
A. Further prompted the reason atorvastatin can inhibit I/
R injury is related with increased NO synthesis and inhibit 
oxidative stress.
  MDA, TSOD are used as indicators of oxidative stress 
status[17-19]. MDA is the major end product of lipid 
metabolism after the biological membrane damage by free 
radicals[20], which may lead to biofilm polyunsaturated fatty 
acid peroxidation and induced cell damage and protein 
synthesis disorders[21]. Therefore detecting MDA may reflect 
the degree of lipid peroxidation and indirectly reflect the 
degree of cell damage. SOD is one of the most important 
antioxidant enzymes in vivo which can specifically clear 
superoxide anion and block the damage to cells caused by 
oxygen free radicals[22] and timely impaired cells[23]. In this 
study, atorvastatin group can reduce the MDA level and 
increased TSOD level of I/R rats. That prompted atorvastatin 
can improve the body’s ability to eliminate oxygen free 
radicals and repair autologous cells, meanwhile inhibit lipid 
peroxidation.
  NT-proBNP as the most sensitive and specific indicator 
of myocardial damage will be increase in a variety of 
pathological conditions[24,25]. In this study, ischemia-
reperfusion group have the highest NT-proBNP, atorvastatin 
group is closer to the sham group which have the lowest NT-
proBNP level, which prompted atorvastatin have a protective 
effect on myocardial cells.
  In summary, atorvastatin has a protective effect on 
the myocardial injury in the myocardial ischemia and 
reperfusion rats. The mechanism may be related to it 
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can increase NO synthesis and decrease MDA content, 
increase serum TSOD activity and the oxidative stress effect, 
meanwhile protect myocardial cells and reduce myocardial 
injury.
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